The SMC accepted the following new drugs for use within NHSScotland:
Amlodipine besylate/valsartan (Exforge®) (350/07) (new formulation)
The SMC accepted the following new drugs for restricted use with NHSScotland:
Ivabradine (Procoralan®) (319/06)
Pioglitazone HCI triple therapy (Actos®) (354/07)
Parathyroid hormone (Preotact) (356-07)
Buprenorphine/naloxone (Suboxone®) (355/07)
The SMC did not recommend the following for use within NHSScotland for their specified uses:
Glyceryl trinitrate 0.4% rectal ointment (Rectogesic®) (200/05)
Lidocaine 5% medicated plaster (Versatis®) (334/06)
Clostridium botulinum type A toxin haemagglutinin complex (Dysport®)
Alglucosidase alfa (Myozyme®) (Source: National Prescribing Centre eCAB Week in Review)
